Amgen, J&J anemia drugs to carry new warning: FDA
33587
Amgen Inc. and Johnson & Johnson anemia drugs will carry strong new warnings after studies showed a higher risk of death and life-threatening side effects in some patients, U.S. health officials said on Friday.
170971
U.S. health officials on Tuesday proposed new warnings about liver and stomach risks on the labels of over-the-counter pain relievers such as aspirin, ibuprofen and acetaminophen.
27933
Amgen Inc.'s  multibillion-dollar anemia drug Aranesp is facing further safety concerns after a medical newsletter reported on Friday that a Danish study of the drug in head and neck cancer was halted due to adverse outcomes seen in patients taking part.
695784
Pfizer Inc.'s Bextra will come with a new warning about possible heart and blood clotting problems when the drug is used by patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.
712529
U.S. regulators will ask an advisory panel for input about the proper dosing for Amgen Inc and Johnson & Johnson anemia drugs in patients with kidney disease, documents released on Friday said.
479663
Lawmakers push to ease restrictions on anemia compounds from Amgen and Johnson & Johnson.
259405
Genentech Inc. said on Thursday it has updated information on the package insert for its colon cancer drug Avastin to reflect an increased risk of blood clots that can cause heart attacks and stroke.
482126
J&J already has generic competition for its new drug.
453423
U.S. cancer doctors on Thursday plan  to ratchet up pressure on the federal Medicare agency to  reverse new limits on use of anemia drugs made by Amgen Inc.  and Johnson & Johnson.
543431
Drugs that treat anemia caused by kidney failure provide important benefits despite the risks for some patients at high doses, Amgen Inc. told a U.S. advisory panel on Tuesday.
34442
Pfizer is the latest drug maker to warn that a product already on the market may pose serious health risks. It took outrage from activists in September to get the Food and Drug Administration to require warning
271163
GAITHERSBURG, Md. - Amgen Inc. and Johnson &amp; Johnson's anemia drugs don't need changes in recommended doses to protect the safety of kidney patients, US advisers said.
202746
Johnson & Johnson JNJ.N is warning  doctors that patients taking its rheumatoid arthritis drug  Remicade may have a higher risk of lymphoma, a blood cancer,  the company said on Friday.
665283
Doctors should stop using the anemia  drug Procrit, made by Johnson & Johnson's Ortho Biotech  Products L.P., if an oxygen-carrying agent in a patient's blood  reaches high levels, the company said in documents released on  Wednesday.
446964
WASHINGTON (CBS.MW) -- The US Food and Drug Administration said on Thursday that Pfizer&#39;s new pain drug Bextra will carry a labeled warning about a risk of cardiac and blood-clotting problems.
531352
NEW YORK/LOS ANGELES  - Amgen Inc  reported sharply lower third-quarter profit on Wednesday on plunging sales of its most important anemia drugs, amid new insurance-coverage restrictions and safety concerns, and on restructuring charges.
564679
Documents released ahead of an FDA meeting foretell a tougher future for Amgen's top drugs.